As the impact of rising interest rates and tighter credit hit home to consumers, retailers will be watching the tills nervously in the run up to Christmas. Lean times may well lie ahead. For the supply chain that means a closer eye kept on costs, inventor
Browsing: Logistics & Supply Chain
For the eleventh outing of the ”Supply Chain Standard” European Supply Chain Excellence Awards we were again delighted to have as our partner PRTM and we are very grateful to PRTM and their partners and consultants across Europe for their input this yea
As supply chain professionals, we should all be taking an active interest in reducing the carbon emissions from our vehicle fleets. This entails better planning, vehicle utilisation and driver training, as well as considering alternative fuel options such
Among this year’s finalists, two entries stood-out for the Sourcing and Procurement Award – Nuon, from the public sector, utilities and services pool, and Vodafone.
Once again the Hi-tech and Electronics sector provided the Overall Winner for this year’s European Supply Chain Excellence Awards. Infineon Technologies deservedly took the top trophy having returned to the competition this year with renewed vigour to com
FMCG is always one of the hardest-fought categories in the Awards, and this year was no exception.
As the British public reel from the tragic news of the loss of four brave firefighters who died in a warehouse fire at a fruit and vegetable packing plant in Atherstone, Warwicks, at the weekend, questions relating to safety procedures and documentation o
The Outstanding Contribution category of the European Supply Chain Excellence Awards is very different from all the others: you, our readers, nominate the candidates, and you vote by email for the winner (and none of those shenanigans that other less repu
Pundits and politicians talk about the need for joined-up thinking, and ERP vendors and systems integrators are equally enthisiastic. But just how joined-up are our supply chains in reality?
Bringing new drugs to market is a very expensive business: typically it can cost over €500 million and – given time limitations on patents – the pharmaceuticals company then has just 5-10 years or so to recoup its investment and make a profit for most the
